Strategic Science & Technologies

Strategic Science & Technologies is a privately-held technology company based in Storrs, United States. The company focuses on commercializing a novel, patented transdermal administration formula designed to deliver pharmaceutical active ingredients more effectively. Their technology aims to provide faster onset of action and therapeutic benefits in areas such as pain management and sexual disorders, enabling physicians to treat various diseases with advanced transdermal solutions.

Strategic Science & Technologies has made significant strides in the healthcare sector, notably through its collaboration with Daré Bioscience, Inc. to develop Sildenafil Cream for Female Sexual Arousal Disorder (FSAD). The company is working towards becoming the first FDA-approved product for FSAD treatment. Key achievements include the initiation of a content validity study and enrollment in a thermography feasibility study, underscoring their commitment to innovative and effective medical treatments.